Evaluating the clinical benefits of anti-cancer drugs approved by Food and Drug Administration for gastrointestinal neoplasms for the past two decades.

Authors: Fares Jamal, Oudai Sahvan, Tanios S. Bekaii-Saab, Mohamad Bassam Sonbol

Published: 2025-01-27

DOI: 10.1200/jco.2025.43.4_suppl.820

Source: Full article

---

Abstract

820